Financials
- Financial year
- 2025
- Total assets
- €1.3m
- Profit
- €349,051
- Solvency
- 10.8%
Total assets▲ 39.6%
Net result
20182025
STUDIO PHARMA
InactiveOverview
Activity
“Het verlenen van advies en support aan de farmaceutische industrie en de overheid, inzake…” (deed in Dutch)
From the articles, 17 activitiesNo NACE code in the KBO yet
Size
€1.3mtotal assets 2025
- Staff
- 4.9 FTE
- Equity
- €138,700
- Profit
- €349,051
Turnover not published (abbreviated or micro format)
Financial health
Inactive: no score
Structure
- Parent
- IN2PHARMA · 100%
3 of 4 deeds read
SignalsneutralLatest accounts filed on timeShow the evidence
Signals
1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-06-2026, 39 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
39 days early
2024
73 days early
2023
14 days early
2022
41 days early
2021
18 days early
2020
16 days early
2019
32 days early
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 7 accounts on average 33 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · abbreviated…
- Restructuring · End & cessationResignation: PHC Group (sole director)…
- RestructuringMerger · Shareholding · Proposal
Key points
By topic
Board & ownership
- Parent
- IN2PHARMA · 100%
Network & group
- Group
- PHC Group
- Connected companies
- 1
- Mergers and asset contributions
- 1
Timeline
- Events
- 25
- Since
- 2008
- 07-01-2026Resignation: GEERAERTS Isabelle (director)
- 19-05-2025Annual accounts filed
- 31-12-2024Highest result from 2018 to 2025
Company details
- Legal form
- Private limited company
- Year ends
- 31-12
- Peppol
- Still in the Peppol directory
Articles of association
- Provisions read
- 3
- Purpose
- “Het verlenen van advies en support aan de farmaceutische industrie en de overheid, inzake…” (deed in Dutch)
Go further with this company
What became of the directors' other companies?Supplier due diligence Who ran this company, and where was it based, on a given date before it ended?Company as of a date How is this company connected to another party?Network investigator
Investigating this company? Keep it with today's facts in a case file.